MTOR and neoplasm: Finally, studies show that KDs help avoid high blood glucose and insulin levels in response to treatment with PI3K, AKT or mTOR inhibitor (the so-called insulin-feedback) and cooperate with these agents in achieving optimal tumor growth control [89].